Accelerating Breakthrough Discoveries into Medicines

2014 Scholar-Innovators

Jayakrishna Ambati, MD
University of Kentucky

Jayakrishna Ambati, MD

Age-related Macular Degeneration (AMD): Development of novel therapeutics to treat AMD, a major cause of blindness in the elderly.

Read More

Darren Carpizo, MD, PhD
Rutgers Cancer Institute of New Jersey

Darren Carpizo, MD, PhD

Cancer: Development of a first-in-kind anticancer drug that restores the function of a commonly mutated gene found in cancer.

Read More

Garret FitzGerald, MD
University of Pennsylvania

Garret FitzGerald, MD

Hypertension and Atherosclerosis: Development of a novel therapeutic for the treatment of hypertension and atherosclerotic disease.

Read More

Mark Humayun, MD, PhD
University of Southern California

Mark Humayun, MD, PhD

Ischemic Retinal Diseases: Development of an innovative oxygen delivery device to treat ischemic retinal diseases, a leading cause of blindness worldwide.

Read More

John Kheir, MD
Harvard University

John Kheir, MD

Hypoxemia and Cardiac Arrest: Development of an injectable form of oxygen to prevent life-threatening hypoxemia in medical emergencies such as cardiac arrest.

Read More

Rahul Kohli, MD, PhD
University of Pennsylvania

Rahul Kohli, MD, PhD

Bacterial Drug Resistance: Development of a novel approach to circumvent bacterial antibiotic resistance in diseases such as cystic fibrosis, tuberculosis and hospital-acquired infections.

Read More

Gavril Pasternak, MD, PhD
Memorial Sloan-Kettering Cancer Center

Gavril Pasternak, MD, PhD

Pain Management: Development of a novel class of analgesics more potent than morphine, but lacking the negative side effects and abuse potential.

Read More

Irina Petrache, MD
Indiana University

Irina Petrache, MD

Chronic Obstructive Pulmonary Disease (COPD): Development of a first-to-market disease-modifying therapy for patients with COPD, the third leading cause of death in the U.S.

Read More

David Rowitch, MD, PhD
University of California, San Francisco

David Rowitch, MD, PhD

Neonatal Brain Injury and Stroke: Development of a novel therapeutic approach to treat neonatal brain injury, Down syndrome and stroke.

Read More

Jean Tang, MD, PhD
Stanford University

Jean Tang, MD, PhD

Basal Cell Carcinoma (BCC): Development of a novel topical drug for the treatment and prevention of BCC, a common form of skin cancer that affects millions worldwide.

Read More

David Wald, MD, PhD
Case Western Reserve University

David Wald, MD, PhD

Acute Myeloid Leukemia (AML): Development of a novel therapeutic to treat AML, the most common form of leukemia in adults.

Read More

Dates to Know

April 5, 2017
Letter of Intent Deadline

LOI Guidelines
Download the Application Guidelines (PDF)

May 31, 2017
Full Application Deadline (For those invited)

December 2017
Awardees Notified

Harrington Project

The Harrington Discovery Institute is the nonprofit arm of the Harrington Project for Discovery & Development, an international initiative supporting breakthrough research by physician-scientists. The Project is a new and powerful approach to address some of the challenges hindering advancement of medicine today.

The Harrington Grant is an important part of the overall pharmaceutical research initiative created by The Harrington Project.

For Questions

For questions about the Scholar-Innovator grants or the application process, please email HDIquestions@HarringtonDiscovery.org.